Cancer Early Detection
Recent advancements in early cancer detection technologies, particularly blood-based multicancer early detection tests, have progressed rapidly. These innovations hold promise in expanding the spectrum of cancers suitable for screening and ultimately reducing cancer mortality. This collection comprises studies recently published in AACR journals, highlighting breakthroughs in early cancer detection. The topics covered span the identification of new biomarkers, the development of innovative methods utilizing specimens beyond blood (such as urine, fecal matter, and breast milk) for single or multiple cancer types, and the design of cancer screening trials to evaluate the tests. Review and commentary articles within this collection provide insights into the current progress, challenges, and future prospects of these technologies, offering a comprehensive overview of the evolving field. Jing Peng, PhD, Associate Editor, Cancer Prevention Research and Cancer Epidemiology, Biomarkers & Prevention ([email protected])
Review
Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies
Sana Raoof; Richard J. Lee; Kunal Jajoo; Joseph D. Mancias; Timothy R. Rebbeck; Steven J. Skates
Doi: 10.1158/1055-9965.EPI-21-1443
Review
Dying To Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection Era
Eric A. Klein; Sarina Madhavan; Tomasz M. Beer; Chetan Bettegowda; Minetta C. Liu; Anne-Renee Hartman; Allan Hackshaw
Doi: 10.1158/1055-9965.EPI-22-1275
Commentary
Cancer Screening Companies Are Rapidly Proliferating: Are They Ready for Business?
Amaia Fernandez-Uriarte; Oscar D. Pons-Belda; Eleftherios P. Diamandis
Doi: 10.1158/1055-9965.EPI-22-0102